Concentra Group Holdings Parent, Inc.

NYSE:CON

Medical - Equipment & Services

Healthcare
$41.98 +0.53%

+$0.15 today

Market cap
$5.31B
Beta
0.82
P/E (TTM)
20.3
EPS (TTM)
$1.41
Dividend yield
0.88%
52W Low $18.55High $28.94

Volume 0.74M

Average 0.90M

CON EBITDA Margin

EBITDA as a percentage of revenue.

Concentra Group Holdings Parent, Inc.NYSE: CON

EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026

EBITDA Margin widens to 21.8%

EBITDA Margin was 21.8% in Q3 FY2026, up 1.4 pp from a year earlier. On a trailing-twelve-month basis it was 20.5%, up 1.3 pp year over year. Over 3 fiscal years it narrowed by 0.2 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 8 analysts of 20.0% for the fiscal year ending Dec 2026, up from 18.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
21.8%-0.5 pp QoQ
Last fiscal yearDec 2025
18.9%-0.5 pp YoY
LTMSep 2026
20.5%+1.3 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.4 pp-0.1 pp-1.5 pp
1 year-0.5 pp+1.1 pp+1.6 pp
3 years-0.2 pp+1.6 pp+1.9 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
18.9%
Year-over-year change
-0.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How CON compares with its peers on the latest reported figures

  • CON's LTM Sep 2026 EBITDA Margin of 20.5% is the 3rd highest of the 10 companies compared; the peer median is 17.0%.
  • Its year-over-year change of +1.3 pp is the 4th highest of 10, against a peer median of +0.7 pp.
  • Over three fiscal years its change of -0.2 pp compares with a peer median of +5.1 pp.
CON Competitors Peer median
EBITDA Margin for CON and competitors
Company Period LTM level YoY 3-year change
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 202656.1% +0.7 pp+5.1 pp
PBHPrestige Consumer Healthcare Inc.LTM Jun 202628.3% -4.0 pp+29.7 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 202620.5% +1.3 pp-0.2 pp
HAEHaemonetics CorporationLTM Jun 202619.3% -8.7 pp-2.2 pp
BHCBausch Health Companies Inc.LTM Jun 202618.9% -14.3 pp-4.5 pp
ITGRInteger Holdings CorporationLTM Jul 202617.0% +0.5 pp-0.6 pp
ADUSAddus HomeCare CorporationLTM Jun 202611.3% +0.7 pp+2.0 pp
HCMHUTCHMED (China) LimitedLTM Jun 2025-1.2% +16.8 pp+86.5 pp
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026-3.5% +10.1 pp+15.6 pp
BEAMBeam Therapeutics Inc.LTM Jun 2026-40.5% +584.3 pp+435.7 pp
Peer median (excluding CON) 17.0%+0.7 pp+5.1 pp

Competitors are the stored peer set for CON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.73B1.72B1.84B1.9B2.16B
Cost of Revenue1.3B1.32B1.33B1.37B1.55B
Gross Profit427.98M408.19M512.43M527.98M613.09M
Gross Margin24.7%23.7%27.9%27.8%28.3%
Research & Development00000
Selling, General & Admin157.71M149.98M152M156.32M203.31M
Operating Expenses157.71M149.98M224.8M223.21M279.1M
Depreciation & Amortization82.21M73.67M73.05M67.18M75.82M
EBITDA389.63M330.2M360.16M368.27M408.93M
EBITDA Margin22.5%19.1%19.6%19.4%18.9%
Operating Income270.27M258.22M287.63M304.76M333.99M
Operating Margin15.6%15.0%15.6%16.0%15.4%
Interest Income00000
Interest Expense31.86M31.64M114.04M69.69M109.29M
Other Income / Expenses5.3M(33.32M)(45M)(73.37M)(110.17M)
Income Before Tax275.56M224.9M242.63M231.39M223.83M
Pre-Tax Margin15.9%13.0%13.2%12.2%10.3%
Income Tax Expense59.53M52.65M57.89M59.5M50.98M
Net Income208.88M166.73M179.95M166.54M166.42M
Net Margin12.1%9.7%9.8%8.8%7.7%
EPS (Basic)1.651.321.421.301.39
EPS (Diluted)1.651.321.421.301.30
Weighted Avg Shares126.59M126.59M126.59M128.13M126.65M
Weighted Avg Shares (Diluted)126.59M126.59M126.59M128.13M128.17M

Concentra Group Holdings Parent, Inc.

NYSE:CON

Intrinsic Alpha fair value

Locked

Current Price

$41.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.